Close



Oct 6, 2021 06:44PM
Sep 21, 2021 05:49PM
Feb 4, 2021 06:59AM
Dec 9, 2020 08:30AM
Nov 20, 2019 04:16PM
Nov 20, 2019 04:16PM
Nov 15, 2019 07:33AM Celgene (CELG) Receives CHMP Positive Opinion for REVLIMID in Combination With Rituximab for Treatment of Adult Patients With Previously Treated Follicular Lymphoma
Nov 15, 2019 07:30AM
Nov 8, 2019 12:33PM
Nov 8, 2019 12:30PM
Nov 6, 2019 11:31AM
Nov 6, 2019 09:06AM
Oct 31, 2019 07:30AM
Sep 9, 2019 07:30AM Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Aug 16, 2019 10:31AM
Aug 16, 2019 10:30AM
Jul 30, 2019 07:30AM
Jul 19, 2019 02:00PM
Jul 19, 2019 01:59PM
Jun 24, 2019 08:57AM
Jun 10, 2019 07:30AM GT Biopharma Company Update
Jun 6, 2019 07:31AM
Jun 6, 2019 07:30AM
Jun 4, 2019 07:32AM
Jun 4, 2019 07:30AM
Jun 3, 2019 09:12AM
Jun 3, 2019 09:00AM
May 28, 2019 12:32PM Celgene (CELG) Announces FDA Approval for REVLIMID in Combination With Rituximab For Treatment of Adults with Previously Treated FL or MZL
May 28, 2019 12:30PM
May 21, 2019 07:52AM
May 21, 2019 07:52AM
May 20, 2019 07:52AM
May 20, 2019 07:52AM
May 16, 2019 08:33AM
May 16, 2019 08:30AM Celgene Receives European Commission Approvals for REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-based Triplet Combination Regimens for Patients with Multiple Myeloma
May 15, 2019 05:04PM
May 13, 2019 07:32AM
May 13, 2019 07:30AM
May 6, 2019 09:00AM
May 1, 2019 05:27PM
May 1, 2019 05:01PM
Apr 26, 2019 07:30AM Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia
Apr 25, 2019 04:30PM
Apr 12, 2019 10:48AM
Apr 12, 2019 10:34AM
Apr 12, 2019 10:33AM
Apr 5, 2019 09:28AM
Apr 5, 2019 09:28AM
Mar 29, 2019 01:33PM Bristol-Myers Squibb Issues Statement on Celgene’s Settlement with Alvogen on Revlimid® Patent Litigation
Mar 29, 2019 11:14AM

251,761 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All